MyFinsight
Home
About
Contact
abcl: the income statement
Download
Download image
Comprehensive loss
-$57,160K
(-13.72%↓ Y/Y)
Foreign currency
translation adjustment
-$41K
(-104.88%↓ Y/Y)
Net loss
-$57,119K
(-11.76%↓ Y/Y)
Income tax recovery
-$11,649K
(-1.08%↓ Y/Y)
Grants and incentives
$2,729K
(-21.83%↓ Y/Y)
Interest income
$6,765K
(-29.55%↓ Y/Y)
Net loss before
income tax
-$68,768K
(-9.80%↓ Y/Y)
Total other income
$7,510K
(-75.80%↓ Y/Y)
License
$138K
Research Fees
$8,817K
Other
-$1,984K
(-111.06%↓ Y/Y)
Loss from operations
-$76,278K
(18.56%↑ Y/Y)
Total revenue
$8,955K
(37.62%↑ Y/Y)
Total operating
expenses
$85,233K
(-14.91%↓ Y/Y)
Depreciation, amortization,
and impairment
$5,247K
(-85.79%↓ Y/Y)
General and
administrative
$22,052K
(15.17%↑ Y/Y)
Sales and marketing
$2,906K
(-7.30%↓ Y/Y)
Research and development
$55,028K
(34.32%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
AbCellera Biologics Inc. (ABCL)
AbCellera Biologics Inc. (ABCL)